ZimVie separation completed

Carly Behm -  

Zimmer Biomet's spine and dental spinoff, ZimVie, completed its separation on schedule March 1.

The March 1 separation date was given in February alongside Zimmer Biomet's fourth quarter results. ZimVie shares will begin trading on the Nasdaq under the symbol "ZIMV," according to a March 1 news release.

Vafa Jamali, who previously worked at Medtronic, leads ZimVie as CEO. The independent spinoff company was first announced in February 2021.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

Featured Learning Opportunities

Featured Webinars

Featured Podcast

Featured Whitepapers